Position in GSK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$85,603,380
-$3,881,520 QoQ
Shares Held
1,633,029
+0.7% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#29
of 1,033 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,542,546,853 across 13 Drug Manufacturers - General names. GSK ranks #10 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
5,307,020 | $1,006,317,132 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,966,523 | $509,698,205 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
8,585,846 | $494,716,446 | |
| 4 | NVO |
Novo Nordisk A S
|
8,270,785 | $396,501,432 | |
| 5 | LLY |
ELI LILLY & Co
|
249,935 | $299,779,562 | |
| 6 | JNJ |
Johnson & Johnson
|
1,127,893 | $286,450,985 | |
| 7 | ABBV |
AbbVie Inc.
|
856,797 | $215,604,397 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
959,904 | $121,274,271 |
All Filings in GSK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,603,380 | 1,633,029 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $89,484,900 | 1,621,397 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $111,084,721 | 2,265,186 | Shares | Defined | 2026-02-13 | |
| 2025-03-31 | $57,859,933 | 1,493,545 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $7,381,417 | 218,256 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $158,185,119 | 3,869,499 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $99,281,759 | 2,578,747 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $90,295,880 | 2,106,272 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $178,627,458 | 4,819,953 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $282,850,122 | 7,802,762 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $292,414,688 | 8,204,677 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $385,573,842 | 10,836,814 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $493,518,459 | 14,044,350 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $236,779,624 | 8,045,519 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $426,498,817 | 9,989,614 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $411,060,025 | 9,621,370 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $313,979,711 | 7,259,096 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $139,652,387 | 3,726,412 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $70,185,271 | 1,797,067 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $96,529,734 | 2,757,618 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $262,164,123 | 7,263,484 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $146,558,406 | 3,969,910 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $168,382,074 | 4,208,833 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $109,707,563 | 2,952,103 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||